Medtronic plc. (NYSE: MDT) and Abbott Laboratories (NYSE: ABT) shares are trading lower on Wednesday after the U.S. Food and Drug Administration (FDA) established a Digital Health Advisory Committee.
What To Know: The FDA's stated purpose of the committee is to, "help the agency explore the complex, scientific and technical issues related to digital health technologies (DHTs), such as artificial intelligence/machine learning (AI/ML), augmented reality, virtual reality, digital therapeutics, wearables, remote patient monitoring and software."
The committee will play an advisory role ...